Skip to main content
. 2019 Apr 5;55(4):95. doi: 10.3390/medicina55040095

Figure 2.

Figure 2

Potential mechanisms of non-type 2 inflammation in CRS patients. TLR, Toll-like Receptor; PAMP, Pathogen Associated Molecule; IFN-γ, Interferon gamma; IL-, Interleukin; MPO, Myeloperoxidase; TNFα, Tumor Necrosis Factor alpha; Th1, T helper 1 cell; Th17 T helper 17 cell; Th22, T helper 22 cell; Treg, regulatory T cell; TGF-β Transforming Growth Factor.